Eden Biodesign LLC
General
Total Cases14
Active Cases2
Patents--
--
--
--
Ratings
Experience
Grade
Trend
DCT
L5
E
PTAB
L5
A
CAFC
L5
E
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 01/24/25 | STIPULATION and Proposed Order to extend certain case deadlines - filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Weinblatt, Richard) Modified on 1/24/2025 (nms). (Entered: 01/24/2025) | |
| 01/24/25 | SO ORDERED, re [93] STIPULATION and Proposed Order to extend certain case deadlines (*Reset Deadlines: Opening Expert Reports due by 2/21/2025, Rebuttal Expert Reports due by 4/10/2025) (see Stipulation for further details). Signed by Judge Richard G. Andrews on 1/24/2025. (nms) (Entered: 01/24/2025) | |
| 01/09/25 | NOTICE OF SERVICE of Defendants Final Initial Invalidity and Unenforceability Contentions Regarding U.S. Patent No. 11,484,527 filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Weinblatt, Richard) (Entered: 01/09/2025) | |
| 01/03/25 | REDACTED VERSION of [82] Letter, by Eden Biodesign, LLC, Allergan Holdings Unlimited Company, AbbVie Inc., AbbVie US LLC. (Attachments: # [1] Proposed Order, # [2] Exhibit A, # [3] Exhibit B, # [4] Exhibit C, # [5] Exhibit D, # [6] Exhibit E, # [7] Exhibit F)(Tigan, Jeremy) Modified on 1/7/2025 (nms). (Entered: 01/03/2025) | |
| 12/30/24 | REDACTED VERSION of [84] Letter by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Attachments: # [1] Text of Proposed Order)(Weinblatt, Richard) (Entered: 12/30/2024) | |
| 12/27/24 | REDACTION NOTICE: In accordance with section G of the Administrative Procedures Governing Filing and Service by Electronic Means, redacted versions of sealed documents shall be filed electronically within 7 days of the filing of the sealed document. The records of this case do not reflect the filing of a redacted version of DI # [84] . (nms) (Entered: 12/27/2024) | |
| 12/18/24 | SO ORDERED Granting [88] Stipulation and Proposed Order regarding infringement (see Order for further details). Signed by Judge Richard G. Andrews on 12/18/2024. (nms) (Entered: 12/18/2024) | |
| 12/18/24 | STIPULATION of Infringement by Eden Biodesign, LLC, Allergan Holdings Unlimited Company, AbbVie Inc., AbbVie US LLC. (Tigan, Jeremy) (Entered: 12/18/2024) | |
| 12/18/24 | Letter to The Honorable Richard G. Andrews, from Jeremy A. Tigan, regarding status. (Tigan, Jeremy) Modified on 12/18/2024 (nms). (Entered: 12/18/2024) | |
| 12/17/24 | ORAL ORDER: The discovery conference scheduled for 12/19/2024, is CANCELED. Ordered by Judge Richard G. Andrews on 12/17/2024. (nms) (Entered: 12/17/2024) |